{"schema_version":"secwatch.filing_event.v1","accession":"0001096752-22-000006","form_type":"8-K","ticker":"EPC","cik":"0001096752","company_name":"EDGEWELL PERSONAL CARE Co","filed_at":"2022-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.408358+00:00","generated_at":"2026-06-27T09:54:39.017248+00:00","sec_items":["2.02","5.07","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Edgewell Q1 net sales up 2.7% to $463.3M; GAAP EPS $0.20 vs $0.32 YoY","bullets":["Net sales $463.3M (+2.7% YoY); organic growth 2.5%. GAAP diluted EPS $0.20, down from $0.32.","Adjusted EPS $0.42, down from $0.43; Billie acquisition reduced adjusted EPS by $0.04.","Board declared $0.15 per share dividend; returned $33M via buybacks and dividends in Q1.","Net debt leverage 3.3x; cash $240M with $221M revolver available.","Company updates FY2022 outlook to include the Billie acquisition; no specific numbers provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001096752-22-000006","json":"https://secwatch.observer/filing/0001096752-22-000006.json","markdown":"https://secwatch.observer/filing/0001096752-22-000006.md","text":"https://secwatch.observer/filing/0001096752-22-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096752/000109675222000006/0001096752-22-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096752/000109675222000006/epc-20220204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T09:54:39.017248+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}